S. Charles Schulz

ORCID: 0000-0003-2711-5273
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Personality Disorders and Psychopathology
  • Bipolar Disorder and Treatment
  • Functional Brain Connectivity Studies
  • Mental Health and Psychiatry
  • Advanced Neuroimaging Techniques and Applications
  • Child and Adolescent Psychosocial and Emotional Development
  • Obsessive-Compulsive Spectrum Disorders
  • Psychotherapy Techniques and Applications
  • Epilepsy research and treatment
  • Psychosomatic Disorders and Their Treatments
  • Treatment of Major Depression
  • Attention Deficit Hyperactivity Disorder
  • Diet and metabolism studies
  • Electroconvulsive Therapy Studies
  • Neural dynamics and brain function
  • Mental Health Research Topics
  • Neurotransmitter Receptor Influence on Behavior
  • Advanced MRI Techniques and Applications
  • Tryptophan and brain disorders
  • Neural and Behavioral Psychology Studies
  • Genetic Associations and Epidemiology
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Pharmaceutical studies and practices
  • Mental Health Treatment and Access

University of Minnesota
2009-2018

Institute of Behavioral Sciences
2007-2017

Minneapolis VA Health Care System
2015

Harvard University
2014

University of Iowa
2014

McLean Hospital
2014

University of Minnesota Medical Center
2004-2014

Resonance Research (United States)
2011

University of Minnesota System
2008

Twin Cities Orthopedics
2008

This study was designed to ascertain the degree and specificity of cognitive impairments in patients with schizophrenia affective disorders.Cognitive function assessed a neuropsychological test battery consecutively admitted (N = 57), unipolar depression 29), bipolar disorder 16).The performance schizophrenic group significantly below that groups disorders on measures attention psychomotor speed, verbal visual memory, problem solving abstraction. IQ lower appeared have deteriorated from...

10.1176/ajp.150.9.1355 article EN American Journal of Psychiatry 1993-09-01

Psychiatric symptoms and cognition were assessed in 13 patients with schizophrenia, one patient schizoaffective disorder, psychosis not otherwise specified while they received a conventional neuroleptic again after an average of 15 months on clozapine. Despite improvements psychiatric symptoms, attention, memory, higher-level problem-solving essentially unchanged. This suggests that certain cognitive deficits are relatively independent psychotic probably central enduring features the...

10.1192/bjp.162.1.43 article EN The British Journal of Psychiatry 1993-01-01

The present study was undertaken to survey the prevalence of mental disorder in juvenile justice facilities and compare health needs for females males. Girls displayed significantly more than boys. estimated boys 27%, compared with 84% girls. difference is highly significant discussed terms service system issues that affect males differently. ©1997 John Wiley & Sons, Ltd.

10.1002/(sici)1099-0798(199721)15:2<195::aid-bsl269>3.0.co;2-8 article EN Behavioral Sciences & the Law 1997-01-01

Twenty-two patients meeting the criteria for borderline or schizotypal personality disorder both participated in a prospective, nonblind 12-week trial of fluoxetine. There were significant reductions self-injury and scores on Hopkins Symptom Checklist regardless diagnosis. The results suggest that controlled trials fluoxetine investigations serotonergic system these disorders would be useful.

10.1176/ajp.148.8.1064 article EN American Journal of Psychiatry 1991-08-01

Previous studies have found varying relationships between cognitive functioning and brain volumes in patients with schizophrenia. However, cortical thickness may more closely reflect cytoarchitectural characteristics than gray matter density or volume estimates. Here, we aimed to compare associations regional variation executive functions, memory, as well verbal spatial processing schizophrenia healthy controls (HCs). We obtained magnetic resonance imaging neuropsychological data for 131 138...

10.1093/schbul/sbr018 article EN Schizophrenia Bulletin 2011-03-24

The authors compared the efficacy and tolerability of low moderate dosages extended-release quetiapine in adults with borderline personality disorder.Ninety-five participants DSM-IV disorder were randomly assigned to receive 150 mg/day (the low-dosage group; N=33), 300 moderate-dosage or placebo (N=29). Total score over time on clinician-rated Zanarini Rating Scale for Borderline Personality Disorder ("Zanarini scale") was analyzed a mixed-effects model accounting informative...

10.1176/appi.ajp.2014.13101348 article EN American Journal of Psychiatry 2014-06-27

Borderline personality disorder (BPD) is associated with symptoms such as affect dysregulation, impaired sense of self, and self-harm behaviors. Neuroimaging research on BPD has revealed structural functional abnormalities in specific brain regions connections. However, little known about the topological organizations networks BPD. We collected resting-state magnetic resonance imaging (fMRI) data from 20 patients 10 healthy controls, constructed frequency-specific by correlating...

10.1016/j.nicl.2016.02.006 article EN cc-by-nc-nd NeuroImage Clinical 2016-01-01

Substance abusers with borderline personality disorder (n = 34) were compared substance who not 89) on measures of impulsivity, coping skills, hostility, negative affect, and triggers for craving or relapse. Borderline abused more substances over the course their lifetime scored significantly higher impulsivity. utilized escape/avoidance mechanisms often, used problem solving positive reappraisal less often than nonborderline abusers. Borderlines had cravings relapses triggered by emotional...

10.1521/pedi.1993.7.3.214 article EN Journal of Personality Disorders 1993-09-01

Regional gray matter (GM) abnormalities are well known to exist in patients with chronic schizophrenia. Voxel-based morphometry (VBM) has been previously used on structural magnetic resonance images (MRI) data characterize these abnormalities. Two multisite schizophrenia studies, the Functional Biomedical Informatics Research Network and Mind Clinical Imaging Consortium, which include 9 collection sites, evaluating efficacy of pooling imaging across centers. Such a could yield increased...

10.1093/schbul/sbn150 article EN Schizophrenia Bulletin 2008-11-09

Background: Emerging evidence implicates white matter (WM) abnormalities in the pathophysiology of schizophrenia. However, there is considerable heterogeneity presentation WM existing studies. The object this study was to evaluate integrity a large sample patients with first-episode (FE) and chronic schizophrenia comparison matched control groups. Our goal assess whether findings occurred early illness or these developed over time. Methods: Participants included 114 (31 FE 83 patients) 138...

10.1093/schbul/sbp088 article EN Schizophrenia Bulletin 2009-09-21

Despite the prevalence and clinical significance of borderline personality disorder, its treatment remains understudied.To evaluate with variably dosed olanzapine in individuals disorder.In this 12-week randomised, double-blind trial, received (2.5-20 mg/day; n=155) or placebo (n=159) (trial registry: NCT00091650). The primary efficacy measure was baseline to end-point change on Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) using last-observation-carried-forward...

10.1192/bjp.bp.107.037903 article EN The British Journal of Psychiatry 2008-12-01

Motivation: Imaging genetics combines brain imaging and genetic information to identify the relationships between variants activities. When data samples belong different classes (e.g. disease status), may exhibit class-specific patterns that can be used facilitate understanding of a disease. Conventional approaches often perform separate analysis on each class report differences, but ignore important shared patterns. Results: In this paper, we develop multivariate method analyze differential...

10.1093/bioinformatics/btw485 article EN Bioinformatics 2016-07-27

This study aims to extend previous research by considering gender differences in borderline personality (BPD) using both dimensional self-reported and clinical measures of symptomatology. Drawing from a cross-cultural, trial sample, the authors compared female male BPD subjects (N = 770; 211 male) between ages 18 65 diagnostic self-report data. The found that women with have greater hostility relationship disruption than men. Gender eating disorders, particularly bulimia, are more divergent...

10.1521/pedi_2014_28_175 article EN Journal of Personality Disorders 2015-01-06
Coming Soon ...